In consistent with the results from AD skin lesions, the IL‐4/IL‐13–treated epidermis for 48 hours clearly showed the intercellular deposition of Gal‐7 at a concentration of 50 ng/mL compared with the control epidermis (Figure 2E). This evidence concerns the gene IL13 and Alzheimer disease.